NCT03500224View on ClinicalTrials.gov

A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2018

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-TAK-954

\[14C\]-TAK-954 intravenous infusion.

Trial Locations (1)

9728 NZ

PRAHS, Groningen

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY

NCT03500224 - A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants | Biotech Hunter | Biotech Hunter